These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27870681)

  • 41. Ablative therapies in renal cell carcinoma.
    Chan AA; Ahrar K; Matin SF
    Minerva Urol Nefrol; 2011 Sep; 63(3):237-50. PubMed ID: 21993322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryoablation vs. radiofrequency ablation for small renal masses.
    Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
    Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
    Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
    World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laparoscopic and percutaneous cryotherapy for renal neoplasms.
    Stroup SP; Kopp RP; Derweesh IH
    Panminerva Med; 2010 Dec; 52(4):331-8. PubMed ID: 21183893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The current management of small renal masses.
    Trinh QD; Saad F; Lattouf JB
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):180-5. PubMed ID: 19553818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous ultrasound-guided radiofrequency ablation of an allograft renal cell carcinoma: a case report.
    Olivani A; Iaria M; Missale G; Capocasale E; Biasini E; Mazzoni MP; Lombardelli L; Luzi E; Frattini A; Pelosi G
    Transplant Proc; 2011 Dec; 43(10):3997-9. PubMed ID: 22172886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Surgical treatment for renal cell carcinoma].
    Roos FC; Rübben H; Stief C; Stöckle M; Thüroff JW
    Dtsch Med Wochenschr; 2010 Feb; 135(6):245-9. PubMed ID: 20127609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on thermal ablation of renal cell carcinoma: oncologic control, technique comparison, renal function preservation, and new modalities.
    Zagoria RJ; Childs DD
    Curr Urol Rep; 2012 Feb; 13(1):63-9. PubMed ID: 22076695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Image-Guided Renal Intervention.
    Frey GT; Sella DM; Atwell TD
    Radiol Clin North Am; 2015 Sep; 53(5):1005-19. PubMed ID: 26321450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New technologies for ablation of small renal tumors: current status.
    Chin JL; Pautler SE
    Can J Urol; 2002 Aug; 9(4):1576-82. PubMed ID: 12243653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
    Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
    Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
    Kunkle DA; Egleston BL; Uzzo RG
    J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results.
    Cornelis FH; Marcelin C; Bernhard JC
    Diagn Interv Imaging; 2017 Apr; 98(4):287-297. PubMed ID: 28011104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
    Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
    BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.